Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Clinical trial NCT03595553 · COMPLETED

Trial details

NCT number: NCT03595553
Sponsor: Summit Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clostridioides Difficile Infection

Start date: 2019-01-28
Primary completion: 2021-11-17
Enrollment: 759

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.